Finance

Lists
Why is MARKSANS down 2,60%?
Dive Deeper
MARKSANS:NSE
Marksans Pharma Ltd
302,90 INR
-2,60%
(-8,10) 1D
19-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MARKSANS...
Open
311,00 INR
High
314,50 INR
Low
302,00 INR
Mkt. cap
137,26 млд
Avg. vol.
2,07 млн
Volume
817,39 миң
Dividend
0,30%
Quarterly dividend
0,22 INR
Ex-dividend date
2026-ж., 20-авг.
P/E ratio
26,55
52-wk high
350,95 INR
52-wk low
155,00 INR
EPS
11,41 INR
Shares outstanding
409,31 млн
No. of employees
2 миң
Open
311,00 INR
High
314,50 INR
Low
302,00 INR
Mkt. cap
137,26 млд
Avg. vol.
2,07 млн
Volume
817,39 миң
Dividend
0,30%
Quarterly dividend
0,22 INR
Ex-dividend date
2026-ж., 20-авг.
P/E ratio
26,55
52-wk high
350,95 INR
52-wk low
155,00 INR
EPS
11,41 INR
Shares outstanding
409,31 млн
No. of employees
2 миң
News stories
From web sources and news partners
About Marksans Pharma Ltd
CEOMark B. Saldanha
Employees1,68 миң
Founded1992
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 13-авг.
Fiscal period
Q1 2027
3,47 INR / 3,30 INR
+5,15%beat
Revenue / Est. (INR)
8,41 млд / 8,50 млд
-1,11%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
7,20 млд
7,54 млд
8,56 млд
8,41 млд
Cost of goods sold
3,09 млд
3,16 млд
4,51 млд
3,43 млд
Cost of revenue
3,09 млд
3,16 млд
4,51 млд
3,43 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,04 млд
1,12 млд
1,21 млд
1,14 млд
Operating expense
2,94 млд
3,02 млд
2,33 млд
3,09 млд
Total operating expenses
6,03 млд
6,18 млд
6,85 млд
6,53 млд
Operating income
1,18 млд
1,36 млд
1,72 млд
1,88 млд
Other non operating income
215,72 млн
201,44 млн
-441,86 млн
63,99 млн
EBT including unusual items
1,33 млд
1,51 млд
2,00 млд
2,07 млд
EBT excluding unusual items
1,33 млд
1,51 млд
1,99 млд
2,07 млд
Income tax expense
341,95 млн
369,34 млн
509,66 млн
471,64 млн
Effective tax rate
25,65%
24,52%
25,48%
22,83%
Other operating expenses
1,64 млд
1,65 млд
881,88 млн
1,70 млд
Net income
982,50 млн
1,13 млд
1,48 млд
1,57 млд
Net profit margin
13,64%
15,01%
17,30%
18,69%
Earnings per share
-
2,50
3,27
3,47
Interest and investment income
-
-
276,78 млн
-
Interest expense
-58,15 млн
-59,35 млн
-63,11 млн
-
Net interest expenses
-58,15 млн
-59,35 млн
213,67 млн
-
Depreciation and amortization charges
269,16 млн
243,27 млн
242,88 млн
248,64 млн
EBITDA
1,43 млд
1,50 млд
1,87 млд
2,04 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору